CSL.AX - CSL Limited

ASX - ASX Delayed price. Currency in AUD

CSL Limited

45 Poplar Road
Parkville, VIC 3052
Australia
61 3 9389 1911
http://www.csl.com.au

SectorHealthcare
IndustryBiotechnology
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Paul R. PerreaultMD, CEO & Exec. DirectorN/AN/A1957
Mr. David Mark Lamont ACA, BComChief Financial Officer1.85MN/A1966
Dr. Andrew CuthbertsonChief Scientific Officer & Director of R&DN/AN/A1955
Mr. Gregory BossExec. VP of Legal & Group Gen. CounselN/AN/A1961
Ms. Elizabeth WalkerExec. VP & Chief HR OfficerN/AN/AN/A
Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. It also operates approximately 140 plasma collection centers. In addition, this segment conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and developsinfluenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Corporate governance

CSL Limited’s ISS governance QualityScore as of 1 September 2018 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 5; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.